Stockscreener 앱 받기
9.38
0.42%
-0.04
전일 마감가:
$9.42
열려 있는:
$9.45
하루 거래량:
1.68M
Relative Volume:
1.15
시가총액:
$836.39M
수익:
$380.79M
순이익/손실:
$49.27M
주가수익비율:
13.40
EPS:
0.7
순현금흐름:
$10.68M
1주 성능:
+0.86%
1개월 성능:
+17.99%
6개월 성능:
+196.84%
1년 성능:
+342.45%
1일 변동 폭
$9.18
$9.55
1주일 범위
$8.47
$9.72
52주 변동 폭
$2.08
$9.72
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
명칭
Amylyx Pharmaceuticals Inc
전화
617-683-0917
주소
43 THORNDIKE STREET, CAMBRIDGE
AMLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals Inc
|
9.38 | 839.96M | 380.79M | 49.27M | 10.68M | 0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-06-24 | 개시 | Guggenheim | Buy |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2025-05-30 | 개시 | TD Cowen | Buy |
| 2025-04-07 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-11-18 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-10-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-03-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2024-03-11 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-11 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-03-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-03-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-01-03 | 개시 | Robert W. Baird | Outperform |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-07-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-03-31 | 개시 | Mizuho | Buy |
| 2023-01-05 | 개시 | BofA Securities | Buy |
| 2022-05-25 | 개시 | Citigroup | Buy |
| 2022-04-01 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
Amylyx Pharmaceuticals Inc 주식(AMLX)의 최신 뉴스
How Amylyx Pharmaceuticals Inc. stock performs during market volatilityRate Hike & Safe Swing Trade Setups - Newser
What data driven models say about Amylyx Pharmaceuticals Inc.’s futureCPI Data & Weekly Top Performers Watchlists - Newser
What momentum shifts mean for Amylyx Pharmaceuticals Inc.July 2025 Closing Moves & Advanced Swing Trade Entry Alerts - Newser
What to expect from Amylyx Pharmaceuticals Inc. in the next 30 daysJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - Newser
Visual trend scoring systems applied to Amylyx Pharmaceuticals Inc.Quarterly Investment Review & Fast Moving Trade Plans - Newser
How hedge fund analytics apply to Amylyx Pharmaceuticals Inc. stockEarnings Growth Report & Entry Point Confirmation Alerts - Newser
Is Amylyx Pharmaceuticals Inc. stock poised for growthWeekly Risk Summary & AI Optimized Trading Strategy Guides - Newser
What high frequency data says about Amylyx Pharmaceuticals Inc.2025 Market Outlook & Verified Momentum Stock Alerts - Newser
Can swing trading help recover from Amylyx Pharmaceuticals Inc. lossesJuly 2025 Final Week & Weekly Top Performers Watchlists - Newser
Can Amylyx Pharmaceuticals Inc. recover in the next quarterM&A Rumor & High Accuracy Swing Trade Signals - Newser
Price action breakdown for Amylyx Pharmaceuticals Inc.July 2025 Weekly Recap & Advanced Swing Trade Entry Plans - Newser
Automated trading signals detected on Amylyx Pharmaceuticals Inc.Market Activity Recap & Target Return Focused Stock Picks - Newser
How sentiment analysis helps forecast Amylyx Pharmaceuticals Inc.2025 Short Interest & Daily Technical Stock Forecast Reports - Newser
Can technical indicators confirm Amylyx Pharmaceuticals Inc.’s reversalJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - Newser
Is Amylyx Pharmaceuticals Inc. stock ready for a breakout2025 Major Catalysts & Accurate Technical Buy Alerts - Newser
Published on: 2025-08-30 13:35:59 - Newser
Is this a good reentry point in Amylyx Pharmaceuticals Inc.July 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
What technical models suggest about Amylyx Pharmaceuticals Inc.’s comebackWeekly Trend Report & Capital Efficiency Focused Strategies - Newser
Ranking Amylyx Pharmaceuticals Inc. among high performing stocks via tools2025 Valuation Update & Daily Chart Pattern Signal Reports - Newser
Is Amylyx Pharmaceuticals Inc. a momentum stock2025 Bull vs Bear & Long-Term Safe Return Strategies - sundaytimes.kr
Can Amylyx Pharmaceuticals Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - newsyoung.net
Using Ichimoku Cloud for Amylyx Pharmaceuticals Inc. technicals2025 Historical Comparison & Stock Market Timing Techniques - Newser
What recovery options are there for Amylyx Pharmaceuticals Inc.Bull Run & Verified Trade Idea Suggestions - Newser
Can trapped investors hope for a rebound in Amylyx Pharmaceuticals Inc.Trade Risk Report & Community Verified Swing Trade Signals - Newser
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Amylyx Pharmaceuticals Inc (AMLX) and Veeva Systems (VEEV) - The Globe and Mail
Amylyx Pharmaceuticals Inc (AMLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):